Corrigendum to “The safety of extended dosing pembrolizumab when compared to traditional dosing: a review and meta-analysis of retrospective studies” [Lung Cancer 204 (2025) 108585]

Lung Cancer · Elsevier

Аннотация

Publication date: November 2026 Source: Lung Cancer, Volume 221 Author(s): Prasanth Sekar, Ashmitha Ashok Kumar, Ian Hughes, Robert Mason, Marcin Dzienis

Читать у издателя →

Похожие статьи